Federal Register / Vol. 78, No. 125 / Friday, June 28, 2013 / Notices 38981 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘LIMITED COMPETITION: 

ENHANCING INVESTMENTS 

COMPARATIVE EFFECTIVENESS 

RESEARCH RESOURCES GRANTS 

(R01)’’. 

DATES: July 23, 2013 (Open on July 23 

from 8:30 a.m. to 9:00 a.m. and closed 

for the remainder of the meeting). 

ADDRESSES: Hyatt Regency Hotel 

Bethesda, One Metro Center, Bethesda, 

MD 20814. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

the ‘‘LIMITED COMPETITION: 

ENHANCING INVESTMENTS 

COMPARATIVE EFFECTIVENESS 

RESEARCH RESOURCES GRANTS 

(R01)’’ are to be reviewed and discussed 

at this meeting. The grant applications 

and the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Dated: June 13, 2013. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2013–15291 Filed 6–27–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Statement of Organization Functions, 

and Delegations of Authority 

Part E, Chapter E (Agency for 

Healthcare Research and Quality), of the 

Statement of Organization, Functions, 

and Delegations of Authority for the 

Department of Health and Human 

Services (61 FR 15955–58, April 10, 

1996, most recently amended at 73 FR 

12737, March 10, 2008) is amended to 

reflect recent organizational changes, 

including renaming of the Office of 

Performance, Accountability, Resources, 

and Technology to the Office of 

Management Services to better reflect its 

functions and the creation of divisions 

within the office. The specific 

amendment is as follows: 

Under Section E–10, Organization, 

delete I. Office of Performance, 

Accountability, Resources, and 

Technology (EQ) and replace with the 

following: 

I. Office of Management Services (EQ) 

Under Section E–20. Functions. 

Delete Office of Performance, 

Accountability, Resources, and 

Technology (EQ) and replace with 

Office of Management Services (EQ). 

Directs and coordinates the Agency’s 

administrative services and operational 

activities. Specifically, the Office 

provides leadership, oversight, and 

executive support for human capital 

management; contracts, grants, and 

financial management; and 

administrative services including safety, 

security, property, space, and facilities 

management, as well as non-information 

technology acquisitions. (1) Office of the 

Director: Leads the design, 

implementation, and evaluation of 

management and operational programs 

that respond to the Agency’s needs. 

Devises strategies to address 

Departmental, Office of Personnel 

Management, and Office of Management 

and Budget initiatives, including 

sustainability and the Agency’s 

conference-approval process, and 

oversees implementation of Agencywide efforts to address these initiatives. 

Conducts complex organizational and 

management analyses and develops 

major proposals and plans. (2) Division 

of Administrative Services: Provides 

oversight and implementation of major 

administrative programs including the 

Agency’s ethics program, Continuity of 

Operations Plans, the Employee Transit 

Benefit Program, quality of worklife 

programs, and physical safety and 

security programs. Manages the 

Agency’s real property and building 

relocation and renovation programs, as 

well as Federal Occupational Health 

activities. Oversees Public Health 

Service Commissioned Corps personnel 

activities and manages Homeland 

Security Presidential Directive 12 

compliance. Provides administrative 

services including timekeeping, travel, 

conference and copy center 

management, mail, and supplies. (3) 

Division of Contracts Management: 

Manages all aspects of the Agency’s 

acquisition program in accordance with 

Federal acquisition regulations policies, 

and initiatives. Oversees and 

implements the Agency’s contract 

planning, solicitation, review, 

negotiation, award, post-award 

administration, payment, and contract 

closeout activities. Develops, 

implements, and maintains policies and 

procedures for the Agency’s acquisition 

program. Provides guidance to the 

contracting officer representative 

community. Manages inter-agency 

agreements, the purchase card program, 

and acquisition workforce training and 

certification programs. (4) Division of 

Financial Management, Performance, 

and Evaluation: Provides guidance in all 

aspects of financial management, 

including Agency budget formulation 

and execution, and ensures integration 

of the budget and planning processes. 

Manages evaluation and measurement 

activities for the Agency including 

development and implementation of the 

Agency’s annual evaluation plan. 

Establishes and maintains financial 

accounting and reporting systems and 

coordinates responses on budget and 

accounting matters with all levels of 

Agency management, Departmental 

staff, Congressional committees, and the 

private sector. Serves as the Agency’s 

focal point for Government Performance 

and Results Act activities and Program 

Integrity activities and coordinates the 

Agency’s efforts for Office of 


tkelley on DSK3SPTVN1PROD with NOTICES
38982 Federal Register / Vol. 78, No. 125 / Friday, June 28, 2013 / Notices 

Management and Budget Circular A– 

123, Management’s Responsibility for 

Internal Control. (5) Division of Grants 

Management: Provides leadership and 

oversight in grants management and 

grants management policy to the 

extramural research community and 

AHRQ extramural staff through expert 

guidance, grant analysis and 

negotiation, outreach, and related 

information dissemination in order to 

promote effective stewardship of AHRQ 

extramural funds in support of 

healthcare research. (6) Division of 

Human Capital and Resources 

Management: Provides guidance to the 

Agency regarding all aspects of 

personnel management including staff 

training, workforce planning and 

restructuring, and allocation and 

utilization of human capital resources. 

Serves as liaison to the Equal 

Employment Opportunity service 

provider and to the servicing personnel 

office to ensure the Agency’s human 

capital needs, including recruitment, 

position classification, and 

compensation, are met and properly 

executed. Manages the Agency’s human 

capital reporting function and 

competitive sourcing activities. Manages 

the Agency’s awards and performance 

management program. 

These changes are effective upon date 

of signature. 

Dated: June 19, 2013. 

Carolyn M. Clancy, 

AHRQ Director. 

[FR Doc. 2013–15289 Filed 6–27–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[Docket No. ATSDR–2013–0001] 

Availability of Draft Toxicological 

Profiles 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (DHHS). 

ACTION: Notice of availability, and 

request for comments. 

SUMMARY: This notice announces the 

availability of Set 25 Toxicological 

Profiles for review and comment. 

Comments can include additional 

information or reports on studies about 

the health effects of Set 25 substances. 

Although ATSDR considered key 

studies for each of these substances 

during the profile development process, 

this Federal Register notice solicits any 

relevant, additional studies, particularly 

unpublished data. ATSDR will evaluate 

the quality and relevance of such data 

or studies for possible inclusion in the 

profile. ATSDR remains committed to 

providing a public comment period for 

this document as a means to best serve 

public health and our clients. The Set 

25 Toxicological Profile is available 

online at http://www.atsdr.cdc.gov/

toxprofiles/index.asp and 

www.regulations.gov, docket ATSDR– 

2013–0001. 

The Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA), as amended by 

the Superfund Amendments and 

Reauthorization Act of 1986 (SARA), 

§ 104(i)(3), [42 U.S.C. 9604(i)(3)], directs 

the ATSDR administrator to prepare 

toxicological profiles of priority 

hazardous substances and, as necessary, 

to revise and publish each updated 

toxicological profile. 

DATES: To be considered, comments on 

the draft toxicological profiles must be 

received not later than September 30, 

2013. Comments received after close of 

the public comment period will be 

considered solely at the discretion of 

ATSDR, based upon what is deemed to 

be in the best interest of the general 

public. 

ADDRESSES: You may submit comments, 

identified by docket number ASTDR– 

2013–0001, by any of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.reguations.gov. Follow the 

instructions for submitting comments. 

• Mail: Division of Toxicology and 

Health and Human Sciences, 1600 

Clifton Rd. NE., MS F57, Atlanta, GA. 

30333. 

Instructions: All submissions received 

must include the agency name and 

docket number for this notice. All 

relevant comments will be posted 

without change. Because all public 

comments regarding ATSDR 

toxicological profiles are available for 

public inspection, no confidential 

business information or other 

confidential information should be 

submitted in response to this notice. 

Refer to the section Submission of 

Nominations (below) for specific 

information required. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Delores Grant, Division of Toxicology 

and Human Health Sciences, 1600 

Clifton Rd. NE., MS F–57, Atlanta, GA 

30333. Phone: 770–488–3351. 

SUPPLEMENTARY INFORMATION: The 

Superfund Amendments and 

Reauthorization Act (SARA) (Pub. L. 

99–499) amends the Comprehensive 

Environmental Response, 

Compensation, and Liability Act 

(CERCLA or Superfund) (42 U.S.C. 9601 

et seq.) by establishing certain 

responsibilities for ATSDR and the U.S. 

Environmental Protection Agency (U.S. 

EPA) with regard to hazardous 

substances most commonly found at 

facilities on the CERCLA National 

Priorities List (NPL). As part of these 

responsibilities, the ATSDR 

administrator must prepare 

toxicological profiles for substances 

enumerated on the priority list of 

hazardous substances. This list 

identifies 275 hazardous substances 

which, according to ATSDR and U.S. 

EPA, pose the most significant potential 

threat to human health. The availability 

of the revised priority list of 275 

hazardous substances was announced in 

the Federal Register on March 6, 2008 

(73 FR 12178). In addition, ATSDR has 

the authority to prepare toxicological 

profiles for substances not found at sites 

on the National Priorities List, in an 

effort to ‘‘. . . establish and maintain 

inventory of literature, research, and 

studies on the health effects of toxic 

substances’’ under CERCLA Section 

104(i)(1)(B). This is also to respond to 

requests for consultation under section 

104(i)(4), and as otherwise necessary to 

support the site-specific response 

actions conducted by ATSDR. 

Each profile will include an 

examination, a summary, and an 

interpretation of available toxicological 

information and epidemiological 

evaluations. This information and these 

data identify the levels of significant 

human exposure for the substance and 

for the associated health effects. The 

profiles must also include a 

determination of whether adequate 

information on the health effects of each 

substance is available or is in the 

process of development. If adequate 

information is not available, ATSDR, in 

cooperation with the National 

Toxicology Program (NTP), is required 

to ensure the initiation of a program of 

research to determine such health 

effects. 

All toxicological profiles issued as 

‘‘Drafts for Public Comment’’ represent 

ATSDR’s best efforts to provide 

important toxicological information on 

priority hazardous substances. 

Set 25 toxicological profiles: 


tkelley on DSK3SPTVN1PROD with NOTICES